G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-thio-p-Nitrophenyl |
|
[beta]-1-thio-p-Nitrophenyl | |
| B4GALT3 | UDP-Gal |
|
4-Me-lumbelyl-[beta] |
|
4-Me-lumbelyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl | |
| B4GALT1 | UDP-Gal |
|
|
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
|---|---|---|---|---|
| B4GALT2 | UDP-Gal |
|
4-Me-lumbelyl-[beta] | |
| B4GALT7 | UDP-Gal |
|
Benzyl-[beta] | |
| B4GALT2 | UDP-Gal |
|
||
| B4GALT7 | UDP-Gal |
|
4-D-MethylUmb-[beta] | |
| B3GNT2 | UDP-GalNAc |
|
[beta]1-OBn |
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Gallus gallus |
| Antimicrobial peptides | Homo sapiens |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Xenopus tropicalis |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 7236228 | The role of extra-hepatic tissues in the receptor-mediated plasma clearance of glycoproteins terminated by mannose or N-acetylglucosamine | Schlesinger PH | 1980 Nov 15 |
|
| 7459337 | Structural analysis of glycosphingolipids by high-resolution proton nuclear magnetic resonance spectroscopy | Dabrowski J | 1980 Nov 01 |
|
| 7419967 | Accumulation of glycoprotein-derived metabolites in neural and visceral tissue in aspartylglycosaminuria | Maury CP | 1980 Nov |
|
| 7460921 | Improved Procedures for Purification of the Bandeiraea simplicifolia I Isolectins and Bandeiraea simplicifolia II Lectin by Affinity Chromatography | DELMOTTE FM | 1980 Nov |
|
| 7449816 | Effect of proglumide on glycoprotein synthesis in aspirin-induced gastric erosions in rats | Umetsu T | 1980 May 30 |
|
| 7372654 | Substrate stabilization of lysozyme to thermal and guanidine hydrochloride denaturation. | Pace CN | 1980 May 10 |
|
| 6989834 | Biosynthesis of lipid A. In vivo formation of an intermediate containing 3-deoxy-D-mannoctulosonate in a mutant of Salmonella typhimurium. | Walenga RW | 1980 May 10 |
|
| 7407676 | Mannose containing glycopeptides of cells derived from human teratocarcinoma (line PA 1) | Rasilo ML | 1980 May 01 |
|
| 6448271 | An indirect assay for canine leukocyte migration inhibitory factor (LIF): Demonstration of its species specificity | Ansfield MJ | 1980 May |
|
| 7371845 | The occurrence of III3‐α‐fucosyllactoneotetraosylceramide in human brain | Vanier MT | 1980 Mar 24 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025